Healthcare

Latest News

[ September 14, 2022 ] SCOTTIE RESOURCES EXTENDS DEPTH OF BLUEBERRY CONTACT ZONE TO 360 METRES WITH INTERCEPT OF 7.07 G/T GOLD OVER 24.55 METRES News Feed
[ September 12, 2022 ] Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference News Feed
[ September 9, 2022 ] Canaquest Launches Mentanine ® (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD News Feed
[ September 6, 2022 ] Zomedica (NYSE American: ZOM) Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association News Feed
[ September 1, 2022 ] Knightscope (Nasdaq: KSCP) Introduces Automatic Criminal Detection Capability News Feed
[ September 1, 2022 ] WISeKey (NASDAQ: WKEY) is Implementing Post–Quantum Algorithms in its Root of Trust Services and Semiconductors for IoT Security News Feed
[ August 30, 2022 ] SCOTTIE RESOURCES DRILLS INTERCEPT OF 13.3 G/T GOLD OVER 12.5 METRES IN FIRST HOLES OF 15,000+ METRE 2022 DRILL PROGRAM News Feed

Eyenovia, Inc (NASDAQ: EYEN) Interview with Dr. Sean Ianchulev

September 18, 2018 The Wall Street Analyzer Comments Off

Eyenovia, Inc (NASDAQ: EYEN) CEO: Dr. Sean Ianchulev THIS INTERVIEW HAS EXPIRED

Valeritas Reports Record Second Quarter Revenue with 36% Year-over-Year Growth

August 8, 2018 The Wall Street Analyzer Comments Off

Company’s Fourth Consecutive Quarter of Record Revenue and Third Consecutive Quarter with Year-Over-Year Revenue Growth Exceeding 20% […]

Contravir (NASDAQ: CTRV) Interview with CEO James Sapirstein in which he discusses recent funding and CRV431 progress

July 9, 2018 The Wall Street Analyzer Comments Off

Contravir Pharmaceuticals (NASDAQ: CTRV) CEO: James Sapirstein INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello Senior Analyst with the Wall Street Analyzer. Joining us today is James Sapirstein CEO for […]

Well Leveraged: VBI Vaccines Outlines Clinical Trial Progress

May 23, 2018 The Wall Street Analyzer Comments Off

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) — Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ:VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, took time to update WSA’s investor […]